✦ LIBER ✦

Lapatinib or trastuzumab in combination with an aromatase inhibitor for first-line treatment of metastatic hormone-receptor-positive breast cancer that overexpresses HER2

✍ Scribed by Sally Doss; Janet Robertson; Jane Adam

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Quality-adjusted survival analysis of fi

✍ Sherrill, Beth; Sherif, Bintu; Amonkar, Mayur M.; Maltzman, Julie; O’Rourke, Lis 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 497 KB

Systematic review of lapatinib in combin

✍ Riemsma, Rob; Forbes, Carol A.; Amonkar, Mayur M.; Lykopoulos, Konstantinos; Dia 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 385 KB

Multicenter phase II study of trastuzuma

✍ M. Venturini; C. Bighin; S. Monfardini; F. Cappuzzo; N. Olmeo; A. Durando; F. Pu 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 218 KB

PCN15 SYSTEMATIC REVIEW OF LAPATINIB PLU

✍ R Riemsma; CA Forbes; M Amonkar; K Lykopoulos; JR Diaz; J Kleijnen; DW Rea 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

An exploratory study of sunitinib in com

✍ Fatima Cardoso; Jean-Luc Canon; Dino Amadori; Daniela Aldrighetti; Jean-Pascal M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 383 KB

Higher efficacy of letrozole in combinat

✍ J. Huober; P.A. Fasching; M. Barsoum; L. Petruzelka; D. Wallwiener; C. Thomssen; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 350 KB